Literature DB >> 15416069

A trial of beta-naphthyldi-2-chloroethylamine in leukemia, Hodgkin's disease, and allied diseases.

W B MATTHEWS.   

Abstract

Entities:  

Keywords:  HODGKIN'S DISEASE; LEUKEMIA; NITROGEN MUSTARDS; POLYCYTHEMIA

Mesh:

Substances:

Year:  1950        PMID: 15416069     DOI: 10.1016/s0140-6736(50)90732-x

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  10 in total

1.  SYMPOSIUM on anti-tumour agents: cytostatic agents.

Authors: 
Journal:  Proc R Soc Med       Date:  1957-01

2.  [Present status of chemotherapy in human neoplastic diseases].

Authors:  J PIRWITZ
Journal:  Klin Wochenschr       Date:  1957-05-01

3.  The chemotherapy of malignant disease.

Authors:  R B SCOTT
Journal:  Br Med J       Date:  1958-01-04

4.  CHEMOTHERAPY of cancer.

Authors: 
Journal:  Br Med J       Date:  1955-10-01

5.  The present status of radiotherapy and chemotherapy in the treatment of chronic leukaemia; a review.

Authors:  M HULBERT
Journal:  Postgrad Med J       Date:  1954-02       Impact factor: 2.401

6.  Cortisone and A.C.T.H. in treatment of non-rheumatic conditions.

Authors:  G M ABER; G N CHANDLER; S J HARTFALL
Journal:  Br Med J       Date:  1954-01-02

7.  [Chemotherapy of malignancies with 2, 4, 6-triethylenimino-s-triazin].

Authors:  G POLEMANN
Journal:  Arch Dermatol Syph       Date:  1952-07

8.  Chemical agents in neoplastic diseases; an evaluation of chemotherapeutic substances for clinical management.

Authors:  H R BIERMAN
Journal:  Calif Med       Date:  1953-01

9.  Oral treatment of polycythaemia vera with beta-naphthyl-di-2-chloroethylamine (R48).

Authors:  K IVERSEN; E MEULENGRACHT
Journal:  Br Med J       Date:  1951-09-01

10.  Trisethylene-imino-s-triazine (triethylene melamine or TEM) in the treatment of neoplastic diseases.

Authors:  M B SHIMKIN; H R BIERMAN; K H KELLY; E LOWENHAUPT; A FURST
Journal:  Calif Med       Date:  1951-07
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.